← Eichor
Condition: Dmd Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Dmd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients Wi
NA · 1 location(s) · Seoul National University Hospital · NCT06363357Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients
EARLY_Phase 1 · 1 location(s) · Shanghai Siponuoyin Biotechnology Co Ltd · NCT07188012phenotypeS in Non Ambulant Duchenne Muscular Dystrophy
Phase N/A · 2 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06366815Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
Phase N/A · 3 location(s) · University of Florida · NCT01484678Natural History of Duchenne Muscular Dystrophy
Phase N/A · 15 location(s) · Genethon · NCT03882827Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Biomarker Development for Muscular Dystrophies
Phase N/A · 5 location(s) · Massachusetts General Hospital · NCT05019625Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
Phase N/A · 3 location(s) · Columbia University · NCT06839469Urinary Titin Biomarker in DMD
NA · 1 location(s) · Children's Hospital of Philadelphia · NCT07332013A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
Phase N/A · 9 location(s) · ITF Therapeutics LLC · NCT07127978Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy
EARLY_Phase 1 · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT06900049FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Phase N/A · 1 location(s) · xCures · NCT06539169Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT06093100Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Phase 1/Phase 2 · 5 location(s) · Wave Life Sciences USA, Inc. · NCT04906460NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
Phase 2 · 25 location(s) · NS Pharma, Inc. · NCT05996003Swiss Registry for Neuromuscular Disorders
Phase N/A · 19 location(s) · University of Bern · NCT05102916Multiparametric Ultrafast Ultrasound Biomarkers for Duchenne and Becker Muscular Dystrophies
Phase N/A · 1 location(s) · Nantes University Hospital · NCT07378553PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)
Phase 1/Phase 2 · 2 location(s) · Precision BioSciences, Inc. · NCT07429240Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old
Phase 2 · 9 location(s) · Italfarmaco · NCT06769633A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
Phase 1/Phase 2 · 15 location(s) · Solid Biosciences Inc. · NCT06138639Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
Phase 2 · 21 location(s) · Satellos Bioscience, Inc. · NCT07287189Examining the Medium-term Effect on Non Inferiority of the Previous Training With the DMD Poppins Clinical for Cognitive
Phase N/A · 2 location(s) · Poppins · NCT06902610Vasodilator and Exercise Study for DMD (VASO-REx)
Phase 2 · 1 location(s) · University of Florida · NCT06290713Duchenne Electronic Health Record Study
Phase N/A · 10 location(s) · The Duchenne Registry · NCT07609394Clinical and Functional Assessment of Patients With Inherited Non-Duchenne Myopathies in Sohag University Hospital
Phase N/A · 3 location(s) · Sohag University · NCT06574919A Registered Cohort Study on Duchenne Muscular Dystrophy
Phase N/A · 1 location(s) · Ning Wang, MD., PhD. · NCT04012671Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
Phase N/A · 33 location(s) · Catalyst Pharmaceuticals, Inc. · NCT06564974Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy
NA · 1 location(s) · Başak Çağla Arslan · NCT06402942Once Weekly Infant Corticosteroid Trial for DMD
Phase 4 · 4 location(s) · Anne M. Connolly · NCT05412394Follow-up of NIV At Home in Patients with Duchenne Muscular Dystrophy
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06773988
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.